Addressing the Challenges in the Identification of HER2-Low and Ultralow Breast Cancer in Asia: A Delphi Consensus
This Delphi study found strong consensus on key concepts for sampling, pathological testing, interpretation, and reporting of HER2-low and ultralow breast cancer. While the opinions expressed align with current guidelines, more evidence on the clinicopathological implications is needed.
Authors
- Sunil Pasricha (ORCID: https://orcid.org/0000-0002-5655-5107)
- Tikamporn Jitpasutham (ORCID: https://orcid.org/0000-0002-9196-1055)
- Rowen Yolo
- M. Shah
- Gong Gyungyub
- Pichet Sampatanukul (ORCID: https://orcid.org/0000-0002-7842-0895)
- Pathmanathan Rajadurai (ORCID: https://orcid.org/0000-0002-9199-1940)
- Shir-Hwa Ueng (ORCID: https://orcid.org/0000-0002-6793-8621)
- Bethy Hernowo
- Puay Hoon Tan
- Benjamin Yongcheng Tan
- Lu Bach Kim
- Irianiwati
- Manuelito A. Madrid
- Trung Nguyen Cong
Institutions
- University of Santo Tomas Hospital (PH)
- Thai Red Cross Society (TH)
- Chulalongkorn University (TH)
- Universitas Gadjah Mada (ID)
- Hanoi Medical University (VN)
- Singapore General Hospital (SG)
- Asan Medical Center (KR)
- King Chulalongkorn Memorial Hospital (TH)
- Dr. Hasan Sadikin General Hospital (ID)
- Rajiv Gandhi Cancer Institute and Research Centre (IN)
- HCMC Hospital of Dermato Venereology (VN)
- St. Luke's Medical Center (PH)
- Cathay General Hospital (TW)
- Yashoda Hospital (IN)
- Subang Jaya Medical Centre (MY)
- University of Santo Tomas (PH)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1007/s12325-025-03426-x
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00